Jet Capital Investors L P Bristol Myers Squibb CO Call Options Transaction History

Jet Capital Investors L P

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $48.2 Million - $53.3 Million	-1,080,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $48.7 Million - $58.1 Million	1,080,200 New	1,080,200 $51.5 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $27.8 Million - $34.6 Million	-550,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $17.9 Million - $20.6 Million	-298,300 Reduced 35.16%	550,000 $34.8 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $50.8 Million - $55.4 Million	848,300	848,300 $52 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Jet Capital Investors L P, based on Form 13F filings with the SEC.

Stay updated on Jet Capital Investors L P with notifications on news.